Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC). Final results of a Phase II study

2002 ◽  
Vol 38 (11) ◽  
pp. S68 ◽  
Author(s):  
S Morales
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
Line Chemotherapy

Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer

2008 ◽  
Vol 63 (5) ◽  
pp. 937-943 ◽  
Author(s):  
Mario Campone ◽  
Maria Blasinska-Morawiec ◽  
Anna Tekiela ◽  
Piotr Koralewski ◽  
Jean-Christophe Pouget ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
Line Chemotherapy

A Phase II Study of Sequential Docetaxel Followed by Doxorubicin/Cyclophosphamide as First-Line Chemotherapy For Metastatic Breast Cancer

2003 ◽  
Vol 4 (4) ◽  
pp. 286-291 ◽  
Author(s):  
Antonio Antón ◽  
Javier Hornedo ◽  
Ana Lluch ◽  
Bartomeu Massuti ◽  
Mónica Corral ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
Line Chemotherapy

Phase II Study of Concurrent Administration of Doxorubicin and Docetaxel as First-Line Chemotherapy for Metastatic Breast Cancer

Oncology ◽  
2003 ◽  
Vol 64 (2) ◽  
pp. 124-130 ◽  
Author(s):  
Tomohiko Aihara ◽  
Yuichi Takatsuka ◽  
Kuniaki Itoh ◽  
Yasutsuna Sasaki ◽  
Noriyuki Katsumata ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
Concurrent Administration ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document